IL94601A - Pharmaceutical preparations containing neptofidil for the treatment of dysuria - Google Patents

Pharmaceutical preparations containing neptofidil for the treatment of dysuria

Info

Publication number
IL94601A
IL94601A IL9460190A IL9460190A IL94601A IL 94601 A IL94601 A IL 94601A IL 9460190 A IL9460190 A IL 9460190A IL 9460190 A IL9460190 A IL 9460190A IL 94601 A IL94601 A IL 94601A
Authority
IL
Israel
Prior art keywords
dysuria
naftopidil
naphth
yloxy
piperazine
Prior art date
Application number
IL9460190A
Other languages
English (en)
Hebrew (he)
Other versions
IL94601A0 (en
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6382247&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL94601(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of IL94601A0 publication Critical patent/IL94601A0/xx
Publication of IL94601A publication Critical patent/IL94601A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
IL9460190A 1989-06-07 1990-06-03 Pharmaceutical preparations containing neptofidil for the treatment of dysuria IL94601A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3918543A DE3918543A1 (de) 1989-06-07 1989-06-07 Verwendung von naftopidil zur therapie der dysurie bei benigner prostata-hypertrophie

Publications (2)

Publication Number Publication Date
IL94601A0 IL94601A0 (en) 1991-04-15
IL94601A true IL94601A (en) 1994-06-24

Family

ID=6382247

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9460190A IL94601A (en) 1989-06-07 1990-06-03 Pharmaceutical preparations containing neptofidil for the treatment of dysuria

Country Status (19)

Country Link
US (1) US5026706A (pt)
EP (1) EP0401653B1 (pt)
JP (1) JPH062673B2 (pt)
KR (1) KR0131452B1 (pt)
AT (1) ATE84416T1 (pt)
AU (1) AU625766B2 (pt)
CA (1) CA2017619C (pt)
DD (1) DD294864A5 (pt)
DE (2) DE3918543A1 (pt)
DK (1) DK0401653T3 (pt)
ES (1) ES2054147T3 (pt)
GR (1) GR3007328T3 (pt)
HK (1) HK46996A (pt)
HU (1) HU206976B (pt)
IE (1) IE62937B1 (pt)
IL (1) IL94601A (pt)
PH (1) PH26690A (pt)
PT (1) PT94268B (pt)
ZA (1) ZA904338B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5474994A (en) * 1992-05-26 1995-12-12 Recordati S.A., Chemical And Pharmaceutical Company Bicyclic heterocyclic derivatives having α1 -adrenergic and 5HT1A
IT1254469B (it) * 1992-02-25 1995-09-25 Recordati Chem Pharm Derivati benzopiranici e benzotiopiranici
US6054432A (en) * 1996-09-12 2000-04-25 Asta Medica Aktiengesellschaft Means for treating prostate hypertrophy and prostate cancer
TW536402B (en) 1998-06-26 2003-06-11 Yamanouchi Pharma Co Ltd Pharmaceutical composition for the therapy of voiding dysfunction
WO2001023405A2 (en) 1999-09-30 2001-04-05 Hollis-Eden Pharmaceuticals, Inc. Therapeutic treatment of androgen receptor driven conditions
JP2001288115A (ja) * 2001-02-07 2001-10-16 Yamanouchi Pharmaceut Co Ltd 下部尿路症治療剤
BR102012000187A2 (pt) * 2012-01-05 2018-04-10 Univ Rio De Janeiro Derivados n-fenilpiperazínicos antagonistas de adrenoceptores a1a, a1d e de receptores 5-ht1a no tratamento da hiperplasia prostática benigna, composições farmacêuticas contendo os mesmos

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL175059C (nl) * 1974-02-23 Boehringer Mannheim Gmbh Bereiding van bloeddrukverlagende stoffen en van preparaten die ze bevatten.

Also Published As

Publication number Publication date
KR910000152A (ko) 1991-01-29
DK0401653T3 (da) 1993-03-29
PT94268A (pt) 1991-02-08
GR3007328T3 (pt) 1993-07-30
EP0401653B1 (de) 1993-01-13
HU903515D0 (en) 1990-10-28
IE902014L (en) 1990-12-07
CA2017619C (en) 1995-06-20
KR0131452B1 (ko) 1998-04-17
IL94601A0 (en) 1991-04-15
ATE84416T1 (de) 1993-01-15
US5026706A (en) 1991-06-25
DD294864A5 (de) 1991-10-17
EP0401653A2 (de) 1990-12-12
ES2054147T3 (es) 1994-08-01
HU206976B (en) 1993-03-01
CA2017619A1 (en) 1990-12-07
EP0401653A3 (de) 1991-07-17
DE3918543C2 (pt) 1991-06-06
AU5628290A (en) 1990-12-13
DE3918543A1 (de) 1990-12-13
JPH062673B2 (ja) 1994-01-12
HUT54494A (en) 1991-03-28
JPH0324014A (ja) 1991-02-01
AU625766B2 (en) 1992-07-16
HK46996A (en) 1996-03-22
IE62937B1 (en) 1995-03-08
PT94268B (pt) 1997-01-31
DE59000748D1 (de) 1993-02-25
ZA904338B (en) 1991-03-27
PH26690A (en) 1992-09-15

Similar Documents

Publication Publication Date Title
WO2005065069A3 (en) Pharmaceutical methods, dosing regimes and dosage forms for the treatment of alzheimer's disease
US2890984A (en) Pharmaceutical composition containing 2-(1, 2, 3, 4-tetrahydro-1-naphthyl)imidazo-line
UA70310C2 (uk) Спосіб лікування ожиріння та комбінований препарат, який містить сибутрамін та орлістат (варіанти)
WO1996022774A2 (en) Combinational drugs for treating migraine and other illnesses, comprising sesquiterpene lactones and b-complex vitamins
AU625766B2 (en) The use of naftpidil for the therapy of dysuria in cases of benign prostatic hypertrophy
AU619420B2 (en) Treatment of depression
US3011945A (en) Phenylcyclopropylamine -10-(omega-aminoalkyl)-phenothiazine ataractic composition
CA1300017C (en) Composition for preventing osteoporosis
EP0190851B1 (en) Improved antiinflammatory composition
BR0316131A (pt) Acetil-l-carnitina para a prevenção e/ou tratamento de neuropatias periféricas induzidas por agentes anti-câncer
OA07029A (fr) Le chlorure de gallium, nouveau médicament anti-cancéreux.
Maronde et al. The Monoamine Oxidase Inhibitor, Pargyline Hydrochloride, and Reserpine: Their Evaluation as Antihypertensive Drugs
NZ245673A (en) Use of naftopidil [ie 1-(2-methoxyphenyl)-4-[3-(naphth-1-yloxy)-2-hydroxypropyl]piperazine] to prepare a medicament for the treatment of dysuria
NZ315632A (en) Process for preparing solid dosage forms of very low-dose drugs comprising admixing 1-3% by weight of carrier particles with a solution of drug in water
JPH02235820A (ja) 血清コレステロール低下剤
LEHMANN A new preparation for sedation in organic brain disease and senile disturbances.
GB2133285A (en) Pharmaceutical compositions
Herbai et al. Normalization of hypercalcaemia of primary hyperparathyroidism by treatment with methallenestril, a synthetic oestrogen with low oestrogenicity
WO2018222163A9 (en) USE OF HERB-BASED PREPARATION CONTAINING POUPINE OIL CONTAINING TREATMENT OF HYPERACTIVE BLADDER AND URINARY INCONTINENCE OF SYMPTOMS OF THE LOWER URINARY SYSTEM
JPH07258081A (ja) 抗ガン剤及びgrpレセプター拮抗剤
JPH02134330A (ja) 解毒剤
Lehmann THERAPEUTIC SEDATION IN BRAIN DISEASE
JP2006028144A (ja) 末梢血行障害による不定愁訴の治療剤
Misevic et al. The Use of Akineton for Parkinsonism
JPS6360926A (ja) 感冒薬

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
KB Patent renewed